Cellibre careers
We are about to witness the next, great industrial revolution. Biology is fundamentally a manufacturing technology. Cells have machinery that is instructed by DNA code turn nutrients into products. We now have the ability to swap out those machines and rewrite that code to turn cells into factories for an almost limitless number of products.
Cellibre deploys this science to transform supply chains across industries. Our first "app" is to reinvent the way cannabis medicines are produced, sourced and consumed. We brew pure, natural cannabinoids like you would brew beer and remove the needs for agriculture from the supply chain completely. What a cannabis farmer can produce in 5,000,000 square feet, we can produce in less than 50,000. We will be an ingredient provider to the pharma, animal health and, where regulations allow, consumer markets.
These products currently sell for thousands or, in some cases, hundreds of thousands per kilogram. We estimate can currently produce our first cannabinoid for less than $2,000 per kilogram (at scale), going to hundreds of dollars over time.
Cellibre deploys this science to transform supply chains across industries. Our first "app" is to reinvent the way cannabis medicines are produced, sourced and consumed. We brew pure, natural cannabinoids like you would brew beer and remove the needs for agriculture from the supply chain completely. What a cannabis farmer can produce in 5,000,000 square feet, we can produce in less than 50,000. We will be an ingredient provider to the pharma, animal health and, where regulations allow, consumer markets.
These products currently sell for thousands or, in some cases, hundreds of thousands per kilogram. We estimate can currently produce our first cannabinoid for less than $2,000 per kilogram (at scale), going to hundreds of dollars over time.
Cellibre hasn't added any jobs yet
Get notified when Cellibre posts new jobs.
Benjamin Chiarelli
Founder of Stealth Biotech, Scrypt Health and Divitempus Ventures; Board of American Made Liner Systems and 83bar; Founder and Director of the 31/21 Foundation
Syndax Pharmaceuticals • New York City • 5 days ago
Akebia Therapeutics • Oakland • $178k – $220k • 7 days ago
Wasatch Microfluidics • Indiana • 7 days ago
Ptc Therapeutics • New Jersey • $198k – $232k • 7 days ago
Fluidigm • Markham • $61k – $88k • 1 week ago
